AbolerIS Pharma
$8.2M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
AbolerIS Pharma is currently valued at $30.0M as of April 10, 2025. The company has raised a total of $49.9M in funding.
Capital Efficiency
With a capital efficiency ratio of 0.60x, AbolerIS Pharma has achieved a valuation that is 0.60 times the total capital raised. This metric indicates room for improvement in capital deployment.
Investment Perspective
AbolerIS Pharma's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is AbolerIS Pharma Worth in 2025?
As of 2025, AbolerIS Pharma is valued at $30.0M, based on the company's Later Stage VC funding round in April 10, 2025. This valuation positions AbolerIS Pharma as one of the leading private companies in the sector.
AbolerIS Pharma Valuation History
AbolerIS Pharma's funding history demonstrates steady growth and investor confidence.
How AbolerIS Pharma Valuation is Determined
Private company valuations like AbolerIS Pharma's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
AbolerIS Pharma Valuation FAQs
Is AbolerIS Pharma profitable?
AbolerIS Pharma has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does AbolerIS Pharma's valuation compare to competitors?
AbolerIS Pharma is valued at $30.0M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will AbolerIS Pharma IPO?
AbolerIS Pharma has not announced plans for an initial public offering. Until an IPO, investors can access AbolerIS Pharma shares through secondary market platforms.